Dequalinium chloride vaginal tablet - Medinova

Drug Profile

Dequalinium chloride vaginal tablet - Medinova

Alternative Names: Fluomizin; Naxyl

Latest Information Update: 04 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Medinova
  • Developer Medinova; Merck & Co; Pierre Fabre; Vivax Pharmaceuticals
  • Class Antifungals; Antineoplastics; Antiseptics; Quinolines; Small molecules
  • Mechanism of Action Cell membrane permeability enhancers; Enzyme inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Bacterial vaginosis; Vulvovaginal candidiasis

Most Recent Events

  • 13 Sep 2016 Duchesnay announces intention to submit NDA to Health Canada
  • 15 Sep 2014 Medinova plans a phase IV trial for Vulvovaginal candidiasis in Thailand (NCT02242695)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top